Legal Cannabis Market Continues to Show Support

Tuesday, April 4, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 4, 2017 /PRNewswire/ -- News Commentary 

The legal cannabis market

is one of the fastest growing industries in the United States, despite the mixed signals from the new government administration. According to a report published by Arcview Market Research, the U.S. cannabis market is
expected to reach $22.6 billion in 2021, with a 27 percent compound annual growth rate during the forecast period. Growing acceptance of cannabis, for either medical or recreational use is the major factor that has led to a surge in the market. Medical cannabis is now legal in more than half of states in the U.S., while eight states have legalized recreational cannabis. SinglePoint, Inc. (OTC: SING), Surna Inc. (OTC: SRNA), Mountain High Acquisitions Corp. (OTC: MYHI), Cannabis Science, Inc. (OTC: CBIS), Medical Marijuana, Inc. (OTC: MJNA)

Troy Dayton, CEO of Arcview Market Research, said: "While the uncertainty created by the mixed signals coming out of the administration may cause a temporary dip in some valuations of cannabis companies and some more risk-averse institutional investors and multinational companies may continue to stay on the sidelines, it won't impact the growth of the market much at all. No matter what the administration does, states will continue to issue cannabis licenses to a long line of applicants, and licensed cannabis outlets will continue to have long lines of consumers ready to purchase this product from regulated establishments."

SinglePoint, Inc. (OTC: SING) on March 14th announced, that it has closed its first round of funding to acquire a portion of Jacksam Corp., DBA Convectium, the developer of a unique oil filling system poised to revolutionize the cannabis market. Convectium projects full-year 2017 sales of $3.5 million, a triple-digit increase over the year prior. The acquisition represents the first of many strategic investments SinglePoint intends to make to diversify its revenue streams in the multi-billion dollar cannabis industry.

"We have evaluated numerous investment prospects in the cannabis space, and found there is nothing that compares to this opportunity we have with Convectium," states SinglePoint CEO, Greg Lambrecht. "With this transaction, we will acquire a stake in a cannabis business that never touches a marijuana plant. This is the strategy we will use as we move forward to hedge us against changing federal and state laws."

Surna Inc. (OTCQB: SRNA) develops and markets novel energy and resource-efficient solutions, including the company's signature water-cooled climate control platform, which meet the highly specific demands of the cannabis industry for temperature, humidity, light and process control. Surna's solutions aim to improve the efficiency, reliability, and overall yield of controlled environment agriculture (CEA).  On February 28th, 2017, Surna signed a contract with Vancouver's Sante Veritas Therapeutic to design and provide equipment for the environmental control system in its first commercial cultivation facility. Surna expects to ship and recognize revenue of $835,000 in the third quarter of 2017.

Mountain High Acquisitions Corp. (OTCQB: MYHI) is a diversified holding company focused on the acquisition and development of businesses within the hemp and CBD nutraceutical sectors. On June 15th, 2016 Mountain High Acquisitions Corp. announced that a 'Think Tank' has been assembled to assist the Company, in a comprehensive restructuring through development of new strategic business and bridge financing plans.

Cannabis Science, Inc. (OTC: CBIS) provides novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. The company specializes in the development of cannabis-based medicines. On March 27th, 2017 the company announced that it has substantially increased its production for its self-medicating patient product line distributed through cannabis dispensaries in California.

Medical Marijuana, Inc. (OTC: MJNA) is a premier cannabis and hemp industry innovator, with a team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. On March 30th, 2017, it announced that its subsidiary HempMeds® Brasil will hold the Country's first-ever symposium, dedicated to providing the Brazilian medical community with information about the medical value of cannabidiol (CBD) and how to legally import CBD into the country for patients. The symposium will take place on April 4 in Rio de Janeiro, and is part of the Company's goal to educate health professionals on the therapeutic uses of cannabis and will feature renowned medical experts and pioneers in the field, like Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico and Chief Executive Officer of Medical Marijuana, Inc., Dr. Stuart Titus. Both will share on the specific therapeutic benefits of CBD, as well as gaining access to medical cannabis for improving health and quality of life.

Please SIGN UP NOW at to Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"

Subscribe Now! Watch us report from NYSE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. has not been compensated directly by any of the companies mentioned here in this editorial. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, has been compensated four thousand two hundred dollars for financial news dissemination and pr services by a third party non affiliate for singlepoint, inc. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information: Media Contact: +1-877-601-1879




Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store